Abstract
Orally administered anti-inflammatory polyamine-based nanomedicines are presented. Inflammation-targeting, radical scavenging, and biocompatible nanomedicines may serve as therapeutic drugs for inflammatory diseases.
Funding Information
  • Japan Society for the Promotion of Science (grant numbers 22K19947, 22H03962, 20H02470)
  • Ministry of Education, Culture, Sports, Science and Technology

This publication has 32 references indexed in Scilit: